FTI Consulting Appoints Healthcare and Life Sciences Expert Andras Fehervary as Senior Advisor
Brussels, 8 December 2020 — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Andras Fehervary, a healthcare and life science industry expert, as a Senior Advisor in its Public Affairs practice within the Strategic Communications segment. He will be based in Brussels.
Mr Fehervary joins FTI Consulting with more than 20 years’ experience in life sciences and regulated industries. He has served as Head of European Public Affairs with Novartis Corporation and with Eli Lilly & Co and has also held combined leadership for European Market Access and Government Affairs with Varian Medical Systems and with Novartis Oncology. He has held pan-EMEIA responsibilities twice, working across Africa, the Middle East, Russia, Turkey and India on a variety of public health and access issues. He was most recently Executive Director Advocacy Europe for Amgen. Mr Fehervary has an extensive network across EMEA in international organizations, the EU and national institutions. He has been a member of the EU Committee of Experts on Rare Diseases, among others.
Hans Hack, a Senior Managing Director and Managing Partner of Brussels in the Strategic Communications segment at FTI Consulting, said, “We are thrilled that Andras is joining FTI Consulting. He brings years of in-house experience at global companies, having tackled important issues for the healthcare and life science sectors. His track record means he will hit the ground running, providing clients with deep policy and market access expertise and top-level counsel at a time when the COVID crisis has re-set Europe’s healthcare landscape.”
Antoine Mialhe, a Managing Director and Head of the Healthcare & Life Sciences practice in Brussels, added, “I am delighted to see Andras joining the team. Throughout his career, Andras worked for some of the world leading life science companies, helping them on a range of market access and government affairs issues. Andras’ expertise will be instrumental to respond to the increasingly complex challenges faced by biotech and pharma companies in bringing innovative drugs to market in Europe.”
Ben Atwell, Global Head of Healthcare & Life Sciences in the Strategic Communications segment at FTI Consulting, said, "We have significantly strengthened our global healthcare credentials in recent years and are excited to welcome Andras as we further build our offering to clients across the EMEA region.”
Commenting on his appointment, Mr Fehervary said, “I’m delighted to join FTI Consulting at this exciting time of unprecedented activity in healthcare. In addition to the many policy topics currently under discussion, 49 new marketing authorisations for new medicines were granted in the US and 66 in Europe last year. As a result of its strengths in strategic communications, public affairs, policy evidence generation, organization and market access, FTI Consulting can help companies achieve their growth objectives whilst improving patient outcomes and strengthening healthcare systems.”
London EC1A 4HD
+32 479 841 866
Source: FTI Consulting, Inc.